Methylation analysis also indicated that the methylation levels of promoter (Fig. S5A) and body (Fig. S5B) regions of ELFN1-AS1 are both aberrant in CRC and READ compared with normal tissues. Here, ELFN1 is linked to colorectal carcinoma.